Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$518.81 - $607.81 $233 Million - $273 Million
-448,411 Reduced 75.93%
142,169 $83 Million
Q1 2024

May 15, 2024

SELL
$473.42 - $539.26 $778 Million - $886 Million
-1,642,625 Reduced 73.55%
590,580 $317 Million
Q4 2023

Feb 14, 2024

BUY
$437.42 - $470.64 $339 Million - $365 Million
775,480 Added 53.2%
2,233,205 $1.03 Billion
Q3 2023

Nov 14, 2023

BUY
$402.4 - $446.42 $376 Million - $417 Million
933,582 Added 178.12%
1,457,725 $634 Million
Q2 2023

Aug 14, 2023

SELL
$354.01 - $427.31 $950 Million - $1.15 Billion
-2,682,937 Reduced 83.66%
524,143 $224 Million
Q1 2023

May 15, 2023

BUY
$335.35 - $386.06 $336 Million - $387 Million
1,002,662 Added 45.48%
3,207,080 $1.14 Billion
Q4 2022

Feb 14, 2023

SELL
$346.68 - $397.58 $140 Million - $161 Million
-404,162 Reduced 15.49%
2,204,418 $827 Million
Q3 2022

Nov 14, 2022

BUY
$321.25 - $373.84 $316 Million - $368 Million
983,065 Added 60.48%
2,608,580 $887 Million
Q2 2022

Aug 15, 2022

BUY
$300.57 - $336.42 $489 Million - $547 Million
1,625,515 New
1,625,515 $530 Million
Q1 2020

May 13, 2020

SELL
$115.75 - $170.96 $175 Million - $258 Million
-1,508,413 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$130.23 - $153.27 $196 Million - $231 Million
1,508,413 New
1,508,413 $209 Million
Q1 2016

May 16, 2016

SELL
N/A
-2,761,995 Closed
0 $0
Q4 2015

Feb 16, 2016

BUY
N/A
487,767 Added 21.45%
2,761,995 $545 Million
Q3 2015

Nov 16, 2015

BUY
N/A
1,648,660 Added 263.55%
2,274,228 $421 Million
Q2 2015

Aug 14, 2015

BUY
N/A
625,568 New
625,568 $141 Million
Q1 2014

May 15, 2014

SELL
N/A
-1,261,574 Closed
0 $0
Q4 2013

Feb 14, 2014

BUY
N/A
1,261,574
1,261,574 $204 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $82.9B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Viking Global Investors LP Portfolio

Follow Viking Global Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Viking Global Investors LP with notifications on news.